Cleared Traditional

K823009 - GAMMA CLQ

K823009 is an FDA 510(k) clearance for GAMMA CLQ, manufactured by Gamma Medical Products, Inc.. The device is a Class 2 Immunology device with product code DAK cleared through the Traditional 510(k) pathway after a 24-day FDA review.

K823009 · Gamma Medical Products, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1982
Decision
24d
Days
Class 2
Risk

K823009 is an FDA 510(k) clearance for the GAMMA CLQ. Classified as Complement C1q, Antigen, Antiserum, Control (product code DAK), Class II - Special Controls.

Submitted by Gamma Medical Products, Inc. (Mchenry, US). The FDA issued a Cleared decision on November 5, 1982 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5240 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K823009

510(k) Number K823009 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 12, 1982
Decision Date November 05, 1982
Days to Decision 24 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
81d faster than avg
Panel avg: 105d · This submission: 24d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DAK Device Classification - Class 2, Special Controls

Product Code DAK Complement C1q, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5240
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DAK Complement C1q, Antigen, Antiserum, Control

All 25
Devices cleared under the same product code (DAK) and FDA review panel - the closest regulatory comparables to K823009.
GMP CIQ ELISA TEST KIT
K833275 · Gamma Medical Products, Inc. · Jun 1984
ORTHO* SERUM ELISA TEST SYSTEM
K833636 · Ortho Diagnostic Systems, Inc. · Jun 1984
SERUM COMPLEMENT ACTIVITY TEST-SCAT
K841541 · Collaborative Research, Inc. · Jun 1984
ORTHO* ALTERNATIVE PATHWAY COMPL. TEST
K821949 · Ortho Diagnostic Systems, Inc. · Aug 1982
ORTHO CLG IMMUNE COMPLEX TEST SYSTEM
K821806 · Ortho Diagnostic Systems, Inc. · Jun 1982
ELECTRO-IMMUNO-QUANTITATION (EIQ)
K792472 · Icl Scientific · Dec 1979
K823009 · GAMMA CLQ
Download PDF Gamma Medical Product…